COVID-19 IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES

被引:0
|
作者
Hasseli, R.
Hoyer, B. F.
Lorenz, H. M.
Pfeil, A.
Regierer, A.
Richter, J.
Schmeiser, T.
Strangfeld, A.
Voll, R.
Schulze-Koops, H.
Krause, A.
Specker, C.
Mueller-Ladner, U.
机构
关键词
D O I
10.1136/annrheumdis-2022-eular.3381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS1246
引用
收藏
页码:957 / 957
页数:1
相关论文
共 50 条
  • [1] COVID-19 in Rituximab treated patients with inflammatory rheumatic diseases
    Haesseli-Frabel, Rebecca
    Hoyer, Bimba Franziska
    Lorenz, Hanns-Martin
    Pfeil, Alexander
    Regierer, Anne C.
    Richter, Jutta G.
    Schmeiser, Tim
    Strangfeld, Anja
    Voll, Reinhard E.
    Schulze-Kops, Hendrik
    Krause, Andreas
    Specker, Christof
    Mueler-Ladner, Ulf
    [J]. INTERNIST, 2022, 63 (SUPPL 3): : 360 - 360
  • [2] Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
    Schulze-Koops, Hendrik
    Krueger, Klaus
    Vallbracht, Inka
    Hasseli, Rebecca
    Skapenko, Alla
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05)
  • [3] COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
    Avouac, Jerome
    Drumez, Elodie
    Hachulla, Eric
    Seror, Raphaele
    Georgin-Lavialle, Sophie
    El Mahou, Soumaya
    Pertuiset, Edouard
    Thao Pham
    Marotte, Hubert
    Servettaz, Amelie
    Domont, Fanny
    Chazerain, Pascal
    Devaux, Mathilde
    Claudepierre, Pascal
    Langlois, Vincent
    Mekinian, Arsene
    Maria, Alexandre Thibault Jacques
    Banneville, Beatrice
    Fautrel, Bruno
    Pouchot, Jacques
    Thomas, Thierry
    Flipo, Rene-Marc
    Richez, Christophe
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (06): : E419 - E426
  • [4] Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
    Dougados, Maxime
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (06): : E395 - E396
  • [5] OUTCOME OF COVID-19 IN PATIENTS WITH RHEUMATIC AND INFLAMMATORY DISEASES TREATED WITH RITUXIMAB: DATA FROM DE FRENCH RMD COVID-19 COHORT
    Avouac, J.
    Drumez, E.
    Hachulla, E.
    Seror, R.
    Georgin-Lavialle, S.
    El Mahou, S.
    Pertuiset, E.
    Pham, T.
    Marotte, H.
    Servettaz, A.
    Domont, F.
    Chazerain, P.
    Devaux, M.
    Claudepierre, P.
    Langlois, V.
    Mekinian, A.
    Maria, A.
    Banneville, B.
    Fautrel, B.
    Pouchot, J.
    Thomas, T.
    Flipo, R. M.
    Richez, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 172 - 173
  • [6] COVID-19 Among Patients With Inflammatory Rheumatic Diseases
    Esatoglu, Sinem Nihal
    Tascilar, Koray
    Babaoglu, Hakan
    Bes, Cemal
    Yurttas, Berna
    Akar, Servet
    Pehlivan, Ozlem
    Akleylek, Cansu
    Tecer, Duygu
    Seyahi, Emire
    Yuce-Inel, Tuba
    Alpay-Kanitez, Nilufer
    Bodakci, Erdal
    Tekgoz, Emre
    Colak, Seda
    Bolek, Ertugrul Cagri
    Koca, Suleyman Serdar
    Kalyoncu, Umut
    Icacan, Ozan Cemal
    Ugurlu, Serdal
    Oz, Hande Ece
    Hamuryudan, Vedat
    Hatemi, Gulen
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [7] COVID-19 and inflammatory rheumatic diseases
    Hasseli, Rebecca
    Ladner, Ulf Muller
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (23) : 1564 - 1568
  • [8] RISK OF COVID-19 IN PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES
    不详
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2021, 125 (01): : 41 - 41
  • [9] Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
    Richez, Christophe
    Lazaro, Estibaliz
    Lemoine, Mael
    Trucheteta, Marie-Elise
    Schaeverbeke, Thierry
    [J]. JOINT BONE SPINE, 2020, 87 (03) : 187 - 189
  • [10] PREDICTORS OF ANTIBODY RESPONSE TO COVID-19 VACCINE IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES. A SWEDISH NATIONWIDE STUDY (COVID19-REUMA)
    Frodlund, M.
    Chatzidionysiou, K.
    Sodergren, A.
    Klingberg, E.
    Hansson, M.
    Pin, E.
    Olsson, S.
    Bengtsson, A.
    Klareskog, L.
    Kapetanovic, M. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 368 - 369